All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
CORT real return snapshot: after CPI-U inflation, CORT returned +62.26% over the past year and +225.31% YTD, with dividends reinvested. Since Apr. 14, 2004, CORT is up +436.11% in real purchasing-power return, or +7.80%/yr, and is currently −5.39% below its real total-return high on Aug. 25, 2026.
Data ending Thu Aug. 27, 2026
| Wed 2004-04-14💬 to Thu 2026-08-27 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| CORT × |
+436.11%
+7.80%/yr |
+13.67%/yr
R2=0.625 |
||||
| Corcept Therapeutics Incorporated NASDAQ Common Stock | ||||||
| Wed 2004-04-14💬 to Thu 2026-08-27 |
Start
Value |
End
Value |
|---|---|---|
| CORT × |
$10,000.00
2004-04-14 |
$53,610.75
2026-08-27 |
| YTD | YoY | |
|---|---|---|
| CORT × | +225.31% | +62.26% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| CORT × |
−5.39%
on 2026-08-27 from 2026-08-25 peak |
−94.69%
on 2006-10-13 |
| Period ending Thu 2026-08-27 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| CORT × | +62.26% |
+217.26% +78.12%/yr |
+237.76% +50.04%/yr |
+343.78% +34.72%/yr |
+1,429.61% +31.36%/yr |
| Year | CORT |
|---|---|
| 2026 (YTD) | +225.31% |
| 2025 | −32.74% |
| 2024 | +50.80% |
| 2023 | +54.74% |
| 2022 | −3.65% |
| 2021 | −29.29% |
| 2020 | +113.29% |
| 2019 | −11.45% |
| 2018 | −27.41% |
| 2017 | +143.61% |
| 2016 | +42.83% |
| 2015 | +64.79% |
| 2014 | −7.24% |
| 2013 | +121.15% |
| 2012 | −58.90% |
| 2011 | −13.95% |
| 2010 | +36.80% |
| 2009 | +165.33% |
| 2008 | −67.02% |
| 2007 | +141.34% |
| 2006 | −67.13% |
| 2005 | −43.54% |
| 2004 | −49.60% |
